Ahead of the G7 Leaders’ Summit, IFPMA and Innovative Medicines Canada (IMC) reaffirm the innovative pharmaceutical industry’s commitment to partnering with G7 governments to improve patient outcomes, strengthen health systems, boost economic growth, and support national security.
Read more
On 17 April 2025, IFPMA and IPASA submitted an open letter to G20 Ministers in support of the advancement of the G20 Health Agenda.
Read moreAhead of the 14th WTO Ministerial Conference (MC14), trade associations representing the pharmaceutical industry provide a perspective on how WTO Members can a roadmap to strengthen global health through meaningful trade policies.
Read more